These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 6140187)
41. Neuroreceptors and ion channels as the basis for drug action: past, present, and future. Narahashi T J Pharmacol Exp Ther; 2000 Jul; 294(1):1-26. PubMed ID: 10871290 [TBL] [Abstract][Full Text] [Related]
42. Distribution and mobility of ion channels and receptors on nerve cell surfaces. Angelides KJ Prog Clin Biol Res; 1990; 343():199-212. PubMed ID: 1696015 [No Abstract] [Full Text] [Related]
43. Lithium: interactions with other drugs. Jefferson JW; Greist JH; Baudhuin M J Clin Psychopharmacol; 1981 May; 1(3):124-34. PubMed ID: 6117583 [No Abstract] [Full Text] [Related]
44. Doctor's orders. Miller L Ment Health Today; 2009 Feb; ():34. PubMed ID: 19266657 [No Abstract] [Full Text] [Related]
45. Graded response to GABA by native extrasynaptic GABA receptors. Lindquist CE; Birnir B J Neurochem; 2006 Jun; 97(5):1349-56. PubMed ID: 16573642 [TBL] [Abstract][Full Text] [Related]
46. [Effect of a specific benzodiazepine antagonist RO 15-1788 on phenazepam-induced inhibition of the evoked potentials in hippocampal neurons]. Glushankov PG; SkrebitskiÄ VG Biull Eksp Biol Med; 1983 Nov; 96(11):65-7. PubMed ID: 6315108 [TBL] [Abstract][Full Text] [Related]
47. Benzodizepines: biochemistry of function. Tallman JF NIDA Res Monogr; 1980; (33):4-11. PubMed ID: 6275270 [No Abstract] [Full Text] [Related]
48. [Psychopharmacological agents as regulators of synaptic plasticity]. Komissarov IV; Abramets II Eksp Klin Farmakol; 1994; 57(5):45-50. PubMed ID: 7696907 [No Abstract] [Full Text] [Related]
49. Receptors for the age of anxiety: pharmacology of the benzodiazepines. Tallman JF; Paul SM; Skolnick P; Gallager DW Science; 1980 Jan; 207(4428):274-81. PubMed ID: 6101294 [TBL] [Abstract][Full Text] [Related]
50. Electrophysiological studies of the mode of action of GABA on vertebrate central neurons. Nistri A; Constanti A; Krnjević K Adv Biochem Psychopharmacol; 1980; 21():81-90. PubMed ID: 6246761 [No Abstract] [Full Text] [Related]
51. Receptor and voltage-operated ion channels in the central nervous system. Antkiewicz-Michaluk L Pol J Pharmacol; 1995; 47(3):253-64. PubMed ID: 8714758 [TBL] [Abstract][Full Text] [Related]
52. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids. Oz M Pharmacol Ther; 2006 Jul; 111(1):114-44. PubMed ID: 16584786 [TBL] [Abstract][Full Text] [Related]
53. GABA(A) receptor subtypes as targets for neuropsychiatric drug development. Korpi ER; Sinkkonen ST Pharmacol Ther; 2006 Jan; 109(1-2):12-32. PubMed ID: 15996746 [TBL] [Abstract][Full Text] [Related]